- Home
-
Press releases
-
Media academy
- Lung Cancer
- Breast Cancer
- Ovarian Cancer
- Head & Neck Cancer
- Targeted Therapy
Boehringer Ingelheim
Prevalence trends in cancer - Global cancer incidence, mortality rates and future trends
Global cancer incidence and mortality rates continue to rise. In 2008 12.7 million patients were diagnosed with cancer while 7.6 million people died of the disease. These numbers are expected to rise to 21.4 million new cases and 13.2 million deaths by 2030.1,2
Evolution of treatments – traditional treatments to targeted therapies
Chemotherapy was one of the major medical advances of the second half of the 20th century. It's an indiscriminate treatment affecting both fast proliferating healthy and cancer cells. Targeted therapy recognises specific targets in or on cancer cells.
From an incurable disease to a chronic condition: changing cancer care
We have seen improvements in cancer diagnosis, management and care. But still there is a high unmet medical need in certain types of cancer.
Source for healthcare professionals: www.inoncology.com
* Nintedanib (BIBF 1120), afatinib (BIBW 2992) and volasertib (BI 6727) are investigational compounds. Their safety and efficacy have not yet been fully established.
